Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hussam Alkaissi

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of the Endocrine Society|May 27, 2024
A Targetable Receptor Tyrosine Kinase in Metastatic Pheochromocytoma and Paraganglioma: A Future Journey for Anlotinib?Hussam Alkaissi, Karel Pacak
The New England Journal of Medicine|February 11, 2026
Belzutifan for Advanced Pheochromocytoma or ParagangliomaHussam Alkaissi, Karel Pacak
Cureus|August 22, 2023
Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and NeurodegenerationHussam Alkaissi, Samy I McFarlane
Cureus|February 22, 2023
Artificial Hallucinations in ChatGPT: Implications in Scientific WritingHussam Alkaissi, Samy I McFarlane
Cureus|May 2, 2023
A Novel Finding of Increased ß-Aminoisobutyric Acid Levels in Classic Homocystinuria With Homocysteine-Lowering TreatmentHussam Alkaissi, Samy I McFarlane
Postgraduate Medical Journal|August 15, 2019
Bilateral parotitis following doxycycline useHussam Alkaissi, Essam Al-Sibahee
The New England Journal of Medicine|November 27, 2024
Belzutifan versus Everolimus for Advanced Renal-Cell CarcinomaHussam Alkaissi, Karel Pacak, Jared Rosenblum
Endocrinology and Metabolism Clinics of North America|May 1, 2026
Pheochromocytomas and ParagangliomasHussam Alkaissi, David Taieb, Hans K Ghayee
The Journal of Clinical Endocrinology and Metabolism|February 20, 2026
Effects of Catecholamines on Bone and Mineral Metabolism in Patients with Pheochromocytoma and ParagangliomaHussam Alkaissi, Karel Pacak, Catherine M Gordon
Biorxiv : the Preprint Server for Biology|April 29, 2026
PPGLomics: An Interactive Platform for Pheochromocytoma and Paraganglioma TranscriptomicsHussam Alkaissi, Catherine M Gordon, Karel Pacak
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of the Endocrine Society|May 27, 2024
A Targetable Receptor Tyrosine Kinase in Metastatic Pheochromocytoma and Paraganglioma: A Future Journey for Anlotinib?Hussam Alkaissi, Karel Pacak
The New England Journal of Medicine|February 11, 2026
Belzutifan for Advanced Pheochromocytoma or ParagangliomaHussam Alkaissi, Karel Pacak
Cureus|August 22, 2023
Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and NeurodegenerationHussam Alkaissi, Samy I McFarlane
Cureus|February 22, 2023
Artificial Hallucinations in ChatGPT: Implications in Scientific WritingHussam Alkaissi, Samy I McFarlane
Cureus|May 2, 2023
A Novel Finding of Increased ß-Aminoisobutyric Acid Levels in Classic Homocystinuria With Homocysteine-Lowering TreatmentHussam Alkaissi, Samy I McFarlane
Postgraduate Medical Journal|August 15, 2019
Bilateral parotitis following doxycycline useHussam Alkaissi, Essam Al-Sibahee
The New England Journal of Medicine|November 27, 2024
Belzutifan versus Everolimus for Advanced Renal-Cell CarcinomaHussam Alkaissi, Karel Pacak, Jared Rosenblum
Endocrinology and Metabolism Clinics of North America|May 1, 2026
Pheochromocytomas and ParagangliomasHussam Alkaissi, David Taieb, Hans K Ghayee
The Journal of Clinical Endocrinology and Metabolism|February 20, 2026
Effects of Catecholamines on Bone and Mineral Metabolism in Patients with Pheochromocytoma and ParagangliomaHussam Alkaissi, Karel Pacak, Catherine M Gordon
Biorxiv : the Preprint Server for Biology|April 29, 2026
PPGLomics: An Interactive Platform for Pheochromocytoma and Paraganglioma TranscriptomicsHussam Alkaissi, Catherine M Gordon, Karel Pacak
Pageof 4